FINNENCE ▪ THE WIRE FILE
THE WIRE · № 80881
News▲ Bullish
Continuous Glucose Monitors Help Type 2 Diabetes Patients Spend Five More Hours a Day in Healthy Blood Sugar Range
KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Trial evidence expands the addressable market for continuous glucose monitors beyond insulin users.
CGM benefits extend to non-insulin type 2 patients
CATALYST TO WATCH
Guideline adoption and reimbursement decisions
MAIN RISK
Trial results may not translate to coverage
FULL DISPATCH
A new large scale clinical trial provides the strongest evidence yet that CGMs can significantly improve blood sugar in people with type 2 diabetes not using insulin AURORA, Colo., Oct. 14, 2026 /PRNewswire/ -- Continuous glucose monitors (CGMs) could transform diabetes management for...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
A $215M financing would split ownership three ways in Rallybio (Nasdaq: RLYB)'s proposed Avenzo merger.2026-10-14 21:16 UTC
A $215M financing would split ownership three ways in Rallybio (Nasdaq: RLYB)'s proposed Avenzo merger.2026-10-14 21:16 UTC
→CORRELATIONshares Healthcare
Several groups send letter to NC attorney general asking for thorough review of WakeMed/Atrium merger2026-10-14 22:12 UTC
Several groups send letter to NC attorney general asking for thorough review of WakeMed/Atrium merger2026-10-14 22:12 UTC
←CORRELATIONshares Healthcare
BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX)2026-10-14 19:22 UTC
BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX)2026-10-14 19:22 UTC
←CORRELATIONshares Healthcare
Veeva to Host Virtual Investor Day on November 5, 20262026-10-14 20:05 UTC
Veeva to Host Virtual Investor Day on November 5, 20262026-10-14 20:05 UTC
←CORRELATIONshares Healthcare
Aurora Cannabis Reiterates Opposition to Curaleaf's Takeover Offer2026-10-14 20:25 UTC
Aurora Cannabis Reiterates Opposition to Curaleaf's Takeover Offer2026-10-14 20:25 UTC
←CORRELATIONshares Healthcare
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year2026-10-14 20:30 UTC
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year2026-10-14 20:30 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.